Summary
Fragile sites are nonrandom, heritable sites on chromosomes that can be induced to form gaps, breaks, and rearrangements under specific conditions. There is currently no established criterion to define a common fragile site. We applied seven published criteria to our data from three groups of subjects: (1) three pairs of like-sexed twins, (2) four unaffected von HippelLindau (VHL) family members, and (3) six patients affected with VHL disease. Substantial differences were present in the numbers of sites considered positive by these criteria. While some of this variability can be attributed to technical factors, our data illustrate the problems in comparing results from different studies to assess the significance of fragile sites. A recently published criterion is based upon the Poisson distribution. We found this criterion to be flawed in its presentation, and furthermore, the Poisson distribution did not provide an adequate approximation to our data. We propose here an alternative approach based upon the negative binomial distribution.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bishop YM, Fienberg SE, Holland PW (1975) Discrete multivariate analysis. Theory and practice. MIT Press, Cambridge, pp 123–130
Craig-Holmes AP, Strong LC, Goodacre A, Pathak S (1987) Variation in the expression of aphidicolin-induced fragile sites in human lymphocyte cultures. Hum Genet 76:134–137
Glover TW, Berger C, Coyle J, Echo B (1984) DNA polymerase-α inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Genet 67:136–142
Hecht F, Glover TW (1984) Cancer chromosome breakpoints and common fragile sites induced by aphidicolin. Cancer Genet Cytogenet 13:185–188
Hecht F, Sutherland GR (1984) Fragile sites and cancer breakpoints. Cancer Genet Cytogenet 12:179–181
Johnson NL, Kotz S (1969) Discrete distributions. Houghton Mifflin, Boston, pp 122–140
Jordan DK, Divelbiss JE, Waziri MH, Burns TL, Patil SR (1989) Fragile site expression in families with von Hippel-Lindau disease. Cancer Genet Cytogenet 39:157–166
Le Beau MM (1986) Chromosomal fragile sites and cancer-specific rearrangements. Blood 67:849–858
Mariani T (1989) Fragile sites and statistics. Hum Genet 81:319–322
Rao PN, Heerema NA, Palmer CG (1988) Fragile sites induced by FUdR, caffeine, and aphidicolin. Their frequency, distribution, and analysis. Hum Genet 78:21–26
Rosner B (1986) Fundamentals of biostatistics, 2nd edn. Duxbury Press, Boston, pp 352–355
Sutherland GR, Ledbetter DH (1989) Report of the committee on cytogenetic markers. (10th International Workshop on Human Gene Mapping) Cytogenet Cell Genet 51:452–458
Tajara EH, Hecht BK, Lockwood D, Bixenman H, Berger CS, Sandberg AA, Hecht F (1988) Fragile sites and genitourinary tumors. Cancer Genet Cytogenet 31:63–68
Wilkinson L (1988) SYSTAT: the system for statistics. SYSTAT, Inc, Evanston, Ill
Yunis JJ (1983) The chromosomal basis of human neoplasia. Science 221:227–236
Yunis JJ, Soreng AL, Bowe AE (1987) Fragile sites are targets of diverse mutagens and carcinogens. Oncogene 1:59–69
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jordan, D.K., Burns, T.L., Divelbiss, J.E. et al. Variability in expression of common fragile sites: in search of a new criterion. Hum Genet 85, 462–466 (1990). https://doi.org/10.1007/BF00194217
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00194217